ChemoCentryx, Inc. (CCXI) has 133 open-market insider trades by 23 insiders since 2012. The most active filer is Susan M. Kanaya, CFO & VP +1.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Vifor Fresenius Medical Care Renal Pharma Ltd. | 10% Owner | — | 4 | $188.1M | 2021-10-12 |
| Glaxosmithkline PLC | — | — | 1 | $171.7M | 2018-10-16 |
| Thomas J. Schall | CEOPres | — | 21 | $65.0M | 2022-10-20 |
| Markus J. Cappel | Treasurer | — | 24 | $48.6M | 2022-10-20 |
| Susan M. Kanaya | CFOVPSecretary | — | 26 | $46.2M | 2022-10-20 |
| Vifor (International) Ltd | 10% Owner | — | 3 | $35.9M | 2020-07-16 |
| Vifor Pharma Ltd. | 10% Owner | — | 2 | $17.9M | 2020-08-03 |
| BVF Inc/il | — | — | 4 | $13.4M | 2015-11-05 |
| Pui San Kwan | — | — | 7 | $12.8M | 2021-03-01 |
| BVF Investments LLC | — | — | 3 | $7.9M | 2015-11-02 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Susan M. Kanaya | CFO & VP +1 | Sell | $2.0M | 2022-08-16 |
| Markus J. Cappel | Treasurer | Sell | $760K | 2022-08-04 |
| Thomas J. Schall | CEO & President | Sell | $6.5M | 2022-08-04 |
| James L. Tyree | Director | Sell | $502K | 2022-08-04 |
| Susan M. Kanaya | CFO & VP +1 | Sell | $4.6M | 2022-08-04 |
| James L. Tyree | Director | Sell | $197K |
Companies that share insiders with CCXI, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2022-06-09 |
| James L. Tyree | Director | Sell | $2.0M | 2021-12-17 |
| Vifor Fresenius Medical Care Renal Pharma Ltd. | 10% Owner | Sell | $157.7M | 2021-10-12 |
| James L. Tyree | Director | Sell | $24K | 2021-05-21 |
| Tausif Butt | COO & VP | Buy | $240K | 2021-05-07 |
| Geoffrey M. Parker | Director | Sell | $3.5M | 2021-03-04 |
| Thomas A. Edwards | Director | Sell | $77K | 2021-03-02 |
| Markus J. Cappel | Treasurer | Sell | $4.5M | 2021-03-01 |
| Pui San Kwan | — | Sell | $459K | 2021-03-01 |
| Thomas A. Edwards | Director | Sell | $28K | 2021-02-09 |